|
|
DIN243 | 小肠癌及小肠组织试验芯片,附病理分级,TNM和临床分期,6例/24点 | 点 数 | 24 | 例 数 | 6 | 行 数 | 3 | 列 数 | 8 | 点直径(mm) | 1.5 | 厚度(µm) | 5.0 | 组织阵列类型 | 石蜡包埋 | 种 属 | 人类 | QA/QC | H&E and IHC confirmed | Applications | Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page. | Notes | 1.Please keep the slides at 4 ℃ after receiving, and make experiment within 3 months will be better. 2.Bake the slides for 30 minutes at 60℃ before the experiment; 3.Please choose a gentle repair method to avoid tissue detachment. |
|
|
|
Legend:
|
|
Malignant (I) Malignant (II) Malignant (IIIB) Malignant (IV) Normal (*)
|
|
|
|
Pos | No | Age | Sex | Organ_Anatomic_Site | Pathology_diagnosis | Grade | TNM | Stage | Type | isBackUp |
A1 | 1 | 30 | M | Small intestine | Small cell carcinoma | * | T3N1M1 | IV | Malignant | N |
A2 | 2 | 30 | M | Small intestine | Small cell carcinoma | * | T3N1M1 | IV | Malignant | N |
A3 | 3 | 63 | M | Small intestine | Adenocarcinoma | 1 | T3N0M0 | II | Malignant | N |
A4 | 4 | 63 | M | Small intestine | Adenocarcinoma | 1 | T3N0M0 | II | Malignant | N |
A5 | 5 | 30 | M | Small intestine | Small cell carcinoma | * | T3N1M1 | IV | Malignant | N |
A6 | 6 | 30 | M | Small intestine | Small cell carcinoma | * | T3N1M1 | IV | Malignant | N |
A7 | 7 | 63 | M | Small intestine | Adenocarcinoma | 1 | T3N0M0 | II | Malignant | N |
A8 | 8 | 63 | M | Small intestine | Adenocarcinoma | 1 | T3N0M0 | II | Malignant | N |
B1 | 9 | 35 | F | Small intestine | Papillary adenocarcinoma | 1 | T2N0M0 | I | Malignant | N |
B2 | 10 | 35 | F | Small intestine | Papillary adenocarcinoma | 1 | T2N0M0 | I | Malignant | N |
B3 | 11 | 57 | M | Small intestine | Mucinous adenocarcinoma | 2--3 | T4N1M0 | IIIB | Malignant | N |
B4 | 12 | 57 | M | Small intestine | Mucinous adenocarcinoma | 2--3 | T4N1M0 | IIIB | Malignant | N |
B5 | 13 | 35 | F | Small intestine | Papillary adenocarcinoma | 1 | T2N0M0 | I | Malignant | N |
B6 | 14 | 35 | F | Small intestine | Papillary adenocarcinoma | 1 | T2N0M0 | I | Malignant | N |
B7 | 15 | 57 | M | Small intestine | Mucinous adenocarcinoma | 2--3 | T4N1M0 | IIIB | Malignant | N |
B8 | 16 | 57 | M | Small intestine | Mucinous adenocarcinoma | 2--3 | T4N1M0 | IIIB | Malignant | N |
C1 | 17 | 35 | M | Small intestine | Small intestine tissue | * | * | * | Normal | N |
C2 | 18 | 35 | M | Small intestine | Small intestine tissue | * | * | * | Normal | N |
C3 | 19 | 30 | M | Small intestine | Small intestine tissue | * | * | * | Normal | N |
C4 | 20 | 30 | M | Small intestine | Small intestine tissue (sparse) | * | * | * | Normal | N |
C5 | 21 | 35 | M | Small intestine | Small intestine tissue | * | * | * | Normal | N |
C6 | 22 | 35 | M | Small intestine | Small intestine tissue | * | * | * | Normal | N |
C7 | 23 | 30 | M | Small intestine | Small intestine tissue | * | * | * | Normal | N |
C8 | 24 | 30 | M | Small intestine | Small intestine tissue (sparse) | * | * | * | Normal | N | Tissue Marker |
|
|